2d
Zacks Investment Research on MSNBiotech Stock Roundup: TSVT Up on BMY Deal, PTGX Up on Data & MoreMergers and acquisitions grabbed the spotlight in the biotech sector once again this week after Bristol Myers Squibb BMY ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
21h
Investor's Business Daily on MSNStock Market Today: Dow Surges 675 Points; This Biotech Name Pops And Tops 3 IBD Lists (Live Coverage)The Dow Jones and S&P 500 posted robust gains Friday afternoon. Nvidia led the Dow and Ulta topped the S&P 500 on the stock ...
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...
AbbVie, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s stock ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Officers, directors, and beneficial owners have shelled out more than $10 million on each of the following four biotech stocks. Wall Street expectations for these stocks are huge for the coming ...
Sutro Biopharma, a Bay Area oncology biotech company, is laying off around half its staff, switching up its leadership team ...
14d
24/7 Wall St. on MSNThe Billionaire Baker Brothers Just Made This Big Biotech Stock MoveIf you’re interested in biotechnology stocks, billionaires Julian and Felix Baker are the ones to turn to. According to Forbes, the brothers, each worth an estimated $2.8 billion, run Baker Bros.
Carvykti's success boosts Legend Biotech Corporation's Q4 2024 sales to $334M, solidifying market position. Click to find out ...
Officers, directors, and beneficial owners have shelled out more than $10 million on each of the following four biotech stocks. Officers, 10% owners, and other insiders have shelled out more than ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results